AMARIN CORP PLC\UK Convertible Preferred Stock, Shares Issued upon Conversion
AMARIN CORP PLC\UK (AMRN) had Convertible Preferred Stock, Shares Issued upon Conversion of 0.1 shares as of 2015-12-31, per its 10-K filed 2016-02-25.
Discontinued › Notes › Equity
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2021-02-25
- 2015-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 0.10 shares.
- 2015-09-30: Convertible Preferred Stock, Shares Issued upon Conversion 0.10 shares.
- 2015-06-30: Convertible Preferred Stock, Shares Issued upon Conversion 0.10 shares.
- 2015-03-31: Convertible Preferred Stock, Shares Issued upon Conversion 1.00 shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2015-12-31 | 0.10 shares 10-K · filed 2016-02-25 |
| 2015-09-30 | 0.10 shares 10-Q · filed 2015-11-04 |
| 2015-06-30 | 0.10 shares 10-Q · filed 2015-08-06 |
| 2015-03-31 | 1.00 shares 10-Q · filed 2015-05-08 |
| 2015-03-05 | 0.10 shares 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |